Dipeptidyl-peptidase IV/CD26 on T cells: analysis of an alternative T-cell activation pathway.
about
Sequence, purification, and cloning of an intracellular serine protease, quiescent cell proline dipeptidaseCaveolin-1 triggers T-cell activation via CD26 in association with CARMA1CD26 Immuno-Expression and Periodontal Disease Progression.Truncation of macrophage-derived chemokine by CD26/ dipeptidyl-peptidase IV beyond its predicted cleavage site affects chemotactic activity and CC chemokine receptor 4 interactionCD26 (dipeptidyl-peptidase IV)-dependent recruitment of T cells in a rat asthma modelAdenosine deaminase: functional implications and different classes of inhibitors.Phase I trial of PT-100 (PT-100), a cytokine-inducing small molecule, following chemotherapy for solid tumor malignancy.Genetic ablation or pharmacological blockade of dipeptidyl peptidase IV does not impact T cell-dependent immune responses.Identity of activation molecule 3 on superantigen-stimulated bovine cells is CD26Cellular targets for angiotensin II fragments: pharmacological and molecular evidence.Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV.Intraindividual changes of dipeptidyl peptidase-IV in peripheral blood of patients with rheumatoid arthritis are associated with the disease activity.Use of Dipeptidyl-Peptidase-4 Inhibitors and the Risk of Pneumonia: A Population-Based Cohort Study.CD26 inhibition enhances allogeneic donor-cell homing and engraftment after in utero hematopoietic-cell transplantation.Therapeutic assessment of glucagon-like peptide-1 agonists compared with dipeptidyl peptidase IV inhibitors as potential antidiabetic drugs.T-cell activation via CD26 and caveolin-1 in rheumatoid synoviumRegulation of dipeptidyl peptidase 8 and 9 expression in activated lymphocytes and injured liver.Talabostat.The in vivo expression of dipeptidyl peptidases 8 and 9.CD26 up-regulates expression of CD86 on antigen-presenting cells by means of caveolin-1.Establishment of monoclonal anti-human CD26 antibodies suitable for immunostaining of formalin-fixed tissue.The dipeptidyl peptidase IV family in cancer and cell biology.CD26/dipeptidylpeptidase IV-chemokine interactions: double-edged regulation of inflammation and tumor biology.CD26 and Asthma: a Comprehensive Review.Enzymatic properties of dipeptidyl aminopeptidase IV produced by the periodontal pathogen Porphyromonas gingivalis and its participation in virulence.Expression profiling of lymphocyte plasma membrane proteins.Characterization of the 4C8 antigen involved in transendothelial migration of CD26(hi) T cells after tight adhesion to human umbilical vein endothelial cell monolayers.Crystal structure of CD26/dipeptidyl-peptidase IV in complex with adenosine deaminase reveals a highly amphiphilic interface.Crystal structures of HIV-1 Tat-derived nonapeptides Tat-(1-9) and Trp2-Tat-(1-9) bound to the active site of dipeptidyl-peptidase IV (CD26).Adenosine Deaminase (ADA)-Deficient Severe Combined Immune Deficiency (SCID): Molecular Pathogenesis and Clinical Manifestations.Plant non-starch polysaccharides that inhibit key enzymes linked to type 2 diabetes mellitus.G1/S cell cycle arrest provoked in human T cells by antibody to CD26.Treatment of Type 2 diabetes mellitus based on glucagon-like peptide-1
P2860
Q22010810-1D23E35F-6878-455C-864D-891DFE5C9FF5Q24296240-DE2035A4-B464-43C4-975C-A6808CE97BA9Q24793434-987D2962-CD93-40A9-A883-E83702F95D2BQ28296438-87837EB9-1DCB-4247-AFF3-2123D893F3B7Q28583786-72283147-0655-4250-9C6C-2948843DAB2EQ32063453-042CDD91-85D9-4096-98E2-39723BB37A75Q33154279-D4EE9B84-E376-4217-A8CF-328CA72F438DQ33428789-52B9FFE2-67B3-42AC-8770-027E97AC6622Q33554619-0F9817EB-1EEE-4831-B857-6C193553357AQ35065512-DBA38BAB-4F29-41C2-B1DD-5B1014BEC271Q35189265-1F91D5E2-B248-4572-B3E8-5C3BF3A02529Q35768486-2A1A96F9-E919-4FEB-9892-0CC3F9A1A602Q35808043-AEFA7607-6FB9-479A-89A8-FD9B4BB1BB44Q35848800-CAC7BF35-C6DD-4368-89BD-A451689BA5B6Q36040879-261E9008-AE6F-4542-8635-430821B614A5Q36452687-05091434-1A03-4D46-8FFA-0D84C1363426Q36865097-10A1D9D0-7DC3-4D4F-AC3E-8C0FEDF16735Q36916883-30FA3477-CCF6-4F4A-9EBA-9FD742CAC10AQ37389403-3E1CE4F2-4CF4-4DAA-8A04-A0B82EFFE033Q37557487-E4B174A3-7B1C-4BD8-947F-59B5438F4A65Q37620932-A8A35A21-F74A-49C6-9CF2-5145BCBF68BAQ37674999-05F4199D-EA6E-4B9F-B89D-CA0E8D0BA33FQ38690194-9F70433A-F679-45CD-9180-B977E4BE37F7Q38937243-1DA5BEB1-BD76-417C-BB1D-398BEB386D57Q39514087-BF8DCAF7-4DFB-4300-9837-59455964F36CQ40624052-52FF8BEF-445F-47A5-8DC9-2279E0DDA0BBQ41847767-BCD1FFEB-500B-4E3F-BAD1-74472885F85CQ44948909-0F973CBA-30C7-41D3-8F13-36E8EC2BBF54Q45254071-8FB0CCC3-75D2-4B38-B52E-09F8FFDA8433Q45871226-DA0756CE-ACFD-4367-9E23-3479DCCC44BDQ50168668-97ABB2B7-73E8-4925-99F7-FFA9D6902322Q52009518-E1DA1F84-A5B8-4A54-AD44-472E4E6E8D71Q58448867-727F51E3-FA27-4DE3-A226-856D1F8E4FEE
P2860
Dipeptidyl-peptidase IV/CD26 on T cells: analysis of an alternative T-cell activation pathway.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Dipeptidyl-peptidase IV/CD26 o ...... ive T-cell activation pathway.
@en
Dipeptidyl-peptidase IV/CD26 o ...... ive T-cell activation pathway.
@nl
type
label
Dipeptidyl-peptidase IV/CD26 o ...... ive T-cell activation pathway.
@en
Dipeptidyl-peptidase IV/CD26 o ...... ive T-cell activation pathway.
@nl
prefLabel
Dipeptidyl-peptidase IV/CD26 o ...... ive T-cell activation pathway.
@en
Dipeptidyl-peptidase IV/CD26 o ...... ive T-cell activation pathway.
@nl
P2093
P2860
P1476
Dipeptidyl-peptidase IV/CD26 o ...... ive T-cell activation pathway.
@en
P2093
P2860
P356
10.1111/J.1600-065X.1998.TB01570.X
P577
1998-02-01T00:00:00Z